Research Article

You have full text access to this OnlineOpen article

Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patients

  1. Julien Haroche*,
  2. Zahir Amoura,
  3. Salim G. Trad,
  4. Bertrand Wechsler,
  5. Philippe Cluzel,
  6. Philippe A. Grenier,
  7. Jean-Charles Piette

Article first published online: 28 SEP 2006

DOI: 10.1002/art.22165

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 10, pages 3330–3336, October 2006

Additional Information

How to Cite

Haroche, J., Amoura, Z., Trad, S. G., Wechsler, B., Cluzel, P., Grenier, P. A. and Piette, J.-C. (2006), Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patients. Arthritis & Rheumatism, 54: 3330–3336. doi: 10.1002/art.22165

Author Information

  1. Hôpital Pitié-Salpêtrière, Paris, France

*Service de Médecine Interne, Hôpital Pitié-Salpêtrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France

Publication History

  1. Issue published online: 28 SEP 2006
  2. Article first published online: 28 SEP 2006
  3. Manuscript Accepted: 17 JUL 2006
  4. Manuscript Received: 21 NOV 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (357K)

REFERENCES

  • 1
    Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75: 157–69.
  • 2
    Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, Cacoub P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) 2004; 83: 371–92.
  • 3
    Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: two cases of orbital involvement. Eye 2000; 14 (Pt 4): 606–12.
  • 4
    Boralevi F, Leaute-Labreze C, Tison F, Bioulac-Sage P, Vital C, Delbrel X, et al. Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association. Ann Dermatol Venereol 1998; 125: 335–8. In French.
  • 5
    Sistermann R, Katthagen BD. Erdheim Chester disease: a rare cause of knee and leg pain. Arch Orthop Trauma Surg 2000; 120: 112–3.
  • 6
    Serratrice J, Granel B, De Roux C, Pellissier JF, Swiader L, Bartoli JM, et al. “Coated aorta”: a new sign of Erdheim-Chester disease. J Rheumatol 2000; 27: 1550–3.
  • 7
    Bourke SC, Nicholson AG, Gibson GJ. Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 2003; 58: 1004–5.
  • 8
    Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001; 85: 1220–4.
  • 9
    Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004; 23: 52–6.
  • 10
    Myra C, Sloper L, Tighe PJ, McIntosh RS, Stevens SE, Gregson RH, et al. Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004; 88: 844–7.
  • 11
    Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol 2003; 21: 232–6.
  • 12
    Boissel N, Wechsler B, Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001; 135: 844–5.
  • 13
    Jakobson AM, Kreuger A, Hagberg H, Sundstrom C. Treatment of Langerhans cell histiocytosis with α-interferon. Lancet 1987; 2: 1520–1.
  • 14
    Palomera L, M Domingo J, Soria J, Gutierrez M. Long term survival in a patient with aggressive Rosai-Dorfman disease treated with interferon α. Med Clin (Barc) 2001; 116: 797–8. In Spanish.
  • 15
    Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α. Blood 2005; 106: 2992–4.
View Full Article (HTML) Get PDF (357K)